GeneDx Holdings Corp.
WGS
$106.65
-$1.70-1.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 101.20% | 71.43% | 70.25% | 81.80% | 76.22% |
| Total Depreciation and Amortization | 20.52% | -9.53% | -22.41% | -38.37% | -20.41% |
| Total Amortization of Deferred Charges | -- | -- | -- | -77.42% | -83.59% |
| Total Other Non-Cash Items | -59.34% | 241.64% | 565.91% | -84.20% | -81.21% |
| Change in Net Operating Assets | 22.71% | 66.39% | 35.29% | -56.59% | -179.58% |
| Cash from Operations | 114.16% | 98.65% | 84.18% | 74.33% | 64.89% |
| Capital Expenditure | -184.71% | -96.33% | -4.59% | 4.42% | 40.26% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -96.22% | -88.99% |
| Cash Acquisitions | -- | -- | -- | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 82.70% | -2.05% | 18.85% | -4.94% | -1,476.78% |
| Cash from Investing | -0.34% | 4.80% | 31.09% | 17.32% | -185.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -18.81% | -21.94% | 42.39% | 34.03% | 31.02% |
| Issuance of Common Stock | 34,930.00% | 715.04% | -66.93% | -89.68% | -99.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 30.18% | 9.74% | -76.29% | -56.72% | -67.47% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 117.96% | 112.31% | 61.56% | 74.96% | 28.96% |